Spontaneous development of myasthenia gravis and myositis following treatment with pembrolizumab: a case report
Abstract Background Immune checkpoint inhibitors are a relatively new advancement in the world of cancer therapy. As such, their adverse effects have yet to be fully understood, with only recent literature documenting autoimmune phenomena secondary to their utilization. Specific immune checkpoint in...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2024-06-01
|
| Serier: | BMC Neurology |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s12883-024-03684-2 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|